{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:38:38Z","timestamp":1794436718968,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","award":["RFO2022"],"award-info":[{"award-number":["RFO2022"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","award":["RFO2023"],"award-info":[{"award-number":["RFO2023"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.atherosclerosis.2025.119178","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T20:25:18Z","timestamp":1743366318000},"page":"119178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Reliability of different formulas for estimating plasma Apolipoprotein B levels in a large cohort of South European individuals"],"prefix":"10.1016","volume":"404","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-0042","authenticated-orcid":false,"given":"Federica","family":"Fogacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serra","family":"Ilayda Yerlitas Tastan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozde","family":"Erturk Zararsiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halef","family":"Okan Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Balbinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokmen","family":"Zararsiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo Francesco Giuseppe","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119178_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/HCO.0000000000001100","article-title":"Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care","volume":"39","author":"Bilgic","year":"2024","journal-title":"Curr. Opin. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119178_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.atherosclerosis.2012.08.039","article-title":"Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study","volume":"225","author":"Sniderman","year":"2012","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119178_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.amjms.2023.07.012","article-title":"Association of apolipoprotein B with all-cause and cardiovascular mortality among adults: results from the national health and nutrition examination surveys","volume":"366","author":"Yan","year":"2023","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119178_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52572","article-title":"Dose-response associations of lipid traits with coronary artery disease and mortality","volume":"7","author":"Yang","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119178_bib5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119178_bib6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/2047487319871733","article-title":"Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: systematic review and meta-analysis of trials","volume":"27","author":"Khan","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2025.119178_bib7","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.3390\/nu15214555","article-title":"The effect of dietary supplementation with plant sterols on total and LDL-cholesterol in plasma is affected by adherence to mediterranean diet: insights from the DESCO randomized clinical study","volume":"15","author":"Cicero","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119178_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119178_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2025.119178_bib10","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib11","unstructured":"Cobas 6000 Analyzer Operator\u2019s Manual. Roche Diagnostics Inc., 9115 Hague Road Indianapolis, IN 46250-0457. Version 5.0."},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib12","unstructured":"Roche APOBT reagent package insert. Version 2012-02, V8. Roche Diagnostics Inc., 9115 Hague Road Indianapolis, IN 46250-0457."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119178_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.117.031982","article-title":"Trends in apolipoprotein B, non-high-density lipoprotein, and low-density lipoprotein for adults 60 Years and older by use of lipid-lowering medications: United States, 2005 to 2006 through 2013 to 2014","volume":"138","author":"Carroll","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib14","article-title":"ApoB measurement system and method","author":"Kulkarni","year":"2008","journal-title":"Age (Chester): DLA PIPER US LLP; IPC8 Class: AG01N3392FI; USPC Class:"},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2840-10-20","article-title":"Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: discriminant Ratio and unbiased equivalence","volume":"10","author":"Hermans","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119178_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051607","article-title":"An equation to estimate the concentration of serum apolipoprotein B","volume":"7","author":"Hwang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1475-2840-11-55","article-title":"Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adults","volume":"11","author":"Cho","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2840-12-39","article-title":"Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM","volume":"12","author":"Hermans","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119178_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/jicc.jicc_34_22","volume":"13","author":"Dorairaj","year":"2023","journal-title":"J Indian Coll Cardiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119178_bib20","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/j.jacl.2024.08.013","article-title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the national lipid association","volume":"18","author":"Soffer","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119178_bib21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"27","key":"10.1016\/j.atherosclerosis.2025.119178_bib22","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/eurheartj\/ehae258","article-title":"Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention","volume":"45","author":"Sniderman","year":"2024","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.119178_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","article-title":"Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population","volume":"37","author":"Tremblay","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1476-511X-9-52","article-title":"A modified formula for calculating low-density lipoprotein cholesterol values","volume":"9","author":"Chen","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-511X-9-27","article-title":"Evaluation of different formulas for LDL-C calculation","volume":"9","author":"Vujovic","year":"2010","journal-title":"Lipids Health Dis."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119178_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3349\/ymj.2017.58.5.975","article-title":"Validation of a newly developed equation for estimating serum apolipoprotein B: associations with cardiovascular disease surrogate markers in Koreans","volume":"58","author":"Kim","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2025.119178_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003644","article-title":"Prediction of future development of cardiovascular disease with an equation to estimate apolipoprotein B: a community-based cohort study","volume":"95","author":"Hwang","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119178_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-017-0549-8","article-title":"Prediction of future cardiovascular disease with an equation to estimate apolipoprotein B in patients with high cardiovascular risk: an analysis from the TNT and IDEAL study","volume":"16","author":"Hwang","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119178_bib29","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.numecd.2021.02.034","article-title":"Application of the Sampson equation to estimate LDL-C in children: comparison with LDL direct measurement and Friedewald equation in the BLIP study","volume":"31","author":"Cicero","year":"2021","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119178_bib30","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.3390\/jcm12103570","article-title":"Concordance of LDL-C estimating equations with direct enzymatic measurement in diabetic and prediabetic subjects","volume":"12","author":"Bolat","year":"2023","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119178_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/jalm\/jfae048","article-title":"Evaluation of 13 formulae for calculated LDL-C using direct homogenous assay in a South Indian population","volume":"9","author":"Ramesh","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.atherosclerosis.2025.119178_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13755-024-00323-5","article-title":"Causal relationship between apolipoprotein B and risk of atherosclerotic cardiovascular disease: a mendelian randomization analysis","volume":"13","author":"Kong","year":"2025","journal-title":"Health Inf. Sci. Syst."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119178_bib33","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/metabo11100690","article-title":"Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target","volume":"11","author":"Behbodikhah","year":"2021","journal-title":"Metabolites"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T09:02:27Z","timestamp":1745571747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025000760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":33,"alternative-id":["S0021915025000760"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119178","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reliability of different formulas for estimating plasma Apolipoprotein B levels in a large cohort of South European individuals","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119178"}}